Resources
Thu, Feb 17, 2022 11:00 AM – 12:00 PM EST Register >> Exacerbated by the pandemic, Mental Health disorder prevalence continues to rise. The growing unmet need is driving a renewed interest in research and development programs. Yet, the complexities of these neurological conditions continue to present challenges. Deep clinical data can offer insights into[…]
OM1’s Dr. Richard Gliklich presents on leveraging the AAO-HFN Reg-ent Registry for research at the FDA-MDEpiNet conference “Cochlear Implant Innovation, Research and Advancement (CIRCA). View Agenda >>
Taylor & Francis Online Published: January 20, 2022 Read the Full Manuscript >> Objective To compare healthcare resource use (HCRU) in patients undergoing sinus surgery with or without steroid-eluting sinus implants. Methods A retrospective, observational cohort study using real-world evidence data (OM1, Inc, Boston, MA, USA) was conducted on adult patients with chronic rhinosinusitis (CRS)[…]
Thu, Feb 17, 2022 11:00 AM – 12:00 PM EST Register >> Exacerbated by the pandemic, Mental Health disorder prevalence continues to rise. The growing unmet need is driving a renewed interest in research and development programs. Yet, the complexities of these neurological conditions continue to present challenges. Deep clinical data can offer insights into[…]
Tue, Jan 25, 2022 12:30 PM – 1:30 PM EST Presenter: Rich Gliklich, CEO, OM1 Register >> Real-World Data (RWD) and Artificial Intelligence (AI) applications are rapidly growing in importance in R&D for Chronic and Immune-mediated Diseases. Join us as we explore: Data Networks The ‘Unstructured’ Medical Record Hybrid Data Collection Data Linkage Artificial Intelligence[…]
